angiotensin ii has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabrini, DA; Dietrich, M; Fernandes, D; Horinouchi, CDS; Machado, W; Moreira, CG; Olchanheski, LR; Otuki, MF; Paludo, K; Pawloski, PL | 1 |
| Ballardie, FW; Chalmers, RJ; Edwards, BD; Lawson, RS; Mitchell, DM; O'Driscoll, JB; Smith, RJ; Testa, HJ | 1 |
| Ballardie, FW; Chalmers, RJ; Edwards, BD; Lawson, RS; O'Driscoll, J; Testa, HJ | 1 |
1 trial(s) available for angiotensin ii and Psoriasis
| Article | Year |
|---|---|
Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
Topics: Adult; Aged; Angiotensin II; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Psoriasis; Renal Circulation; Renin-Angiotensin System; Risk Factors | 1994 |
2 other study(ies) available for angiotensin ii and Psoriasis
| Article | Year |
|---|---|
Aliskiren: Preclinical evidence for the treatment of hyperproliferative skin disorders.
Topics: Amides; Angiotensin II; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Cardiovascular System; Disease Models, Animal; Female; Fumarates; Inflammation; Keratinocytes; Mice; Psoriasis; Renin; Renin-Angiotensin System; Skin Diseases | 2018 |
Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin.
Topics: Adolescent; Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemodynamics; Hormones; Humans; Male; Middle Aged; Nifedipine; Psoriasis; Renal Circulation | 1993 |